Amylyx Pharmaceuticals (AMLX) Selling, General & Administrative (2021 - 2026)
Amylyx Pharmaceuticals (AMLX) recorded Selling, General & Administrative of $21.93 million in Q2 2026, up 40.2% from $15.64 million a year earlier and up 35.6% from the prior quarter.
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Selling, General & Administrative (2021 - 2026) Analysis & Trends
On a TTM basis, Amylyx Pharmaceuticals' Selling, General & Administrative came in at $69.66 million as of Jun 30, 2026, up 5.1% year-over-year; for FY2025, it came in at $62.89 million, down 45.0% from FY2024.
- Annual Selling, General & Administrative has a four-year compound annual growth rate of 12.7% (FY2021 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $114.33 million in FY2024 (-39.3%), $188.36 million in FY2023 (+48.2%), $127.13 million in FY2022 (+226.5%) and $38.93 million in FY2021.
- The Q2 2026 figure is the highest quarterly Selling, General & Administrative since Q1 2024.
- On a year-over-year basis, Selling, General & Administrative rose in two of the last eight quarters, with an average decline of 25.9%.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 338.9% in Q1 2022, against a decline of 72.8% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $16.17 million (Q1 2026), $15.39 million (Q4 2025) and $16.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Amylyx Pharmaceuticals | 3.13 Bn | 3.13 Bn | - | 21.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.93 Mn |
| Mar 31, 2026 | 16.17 Mn |
| Dec 31, 2025 | 15.39 Mn |
| Sep 30, 2025 | 16.17 Mn |
| Jun 30, 2025 | 15.64 Mn |
| Mar 31, 2025 | 15.68 Mn |
| Dec 31, 2024 | 17.10 Mn |
| Sep 30, 2024 | 17.83 Mn |
| Jun 30, 2024 | 21.65 Mn |
| Mar 31, 2024 | 57.76 Mn |
| Dec 31, 2023 | 52.24 Mn |
| Sep 30, 2023 | 48.72 Mn |
| Jun 30, 2023 | 43.39 Mn |
| Mar 31, 2023 | 44.01 Mn |
| Dec 31, 2022 | 40.84 Mn |
| Sep 30, 2022 | 29.94 Mn |
| Jun 30, 2022 | 29.99 Mn |
| Mar 31, 2022 | 26.35 Mn |
| Dec 31, 2021 | 14.92 Mn |
| Sep 30, 2021 | 10.35 Mn |
API Access
Amylyx Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AMLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "AMLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AMLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();